Decas Earns Cranberry Patent for Controlling Metabolic Syndrome


The company now holds 10 worldwide cranberry ingredient patents.

Decas Botanical Synergies LLC (Carver, MA) has secured a cranberry-based patent, U.S. patent #8,173,178, for controlling metabolic syndrome. The patent is labeled “Compositions and methods for controlled metabolic syndrome using whole fruit-derived cranberry ingredient profile enriched in stress adopted bioactives (SABs).”

“We look forward to partnering with leading nutritional supplement and healthcare providers to penetrate the market for natural cranberry-based solutions for controlling metabolic syndrome,” said Dan Souza, senior director of sales and marketing at Decas Botanical. “This patent, coupled with out published work linking cranberry to prostate health, illustrates DBS’ commitment to expanding the cranberry market beyond prevention of urinary tract infections.”

Decas now holds 10 worldwide patents for cranberry ingredients.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.